• Nem Talált Eredményt

Acid Elith Praetorius Principle

N/A
N/A
Protected

Academic year: 2022

Ossza meg "Acid Elith Praetorius Principle"

Copied!
2
0
0

Teljes szövegt

(1)

500

Uric Acid

Elith Praetorius Principle

The enzyme uricase catalyses the reaction:

(1) Uric acid + 02 + 2 H20 > allantoin + H202 + C 02

The measure of the reaction is the decrease in optical density at 293 m\i due to the oxidation of uric acid. This decrease is proportional to the uric acid concentration.

Reagents *>

1. Glycine, A. R.

2. Sodium hydroxide, A. R., I N 3. Uricase

lyophilized preparation in ampoules or as a suspension in 1 0 % a m m o n i u m sulphate solution.

Commercial preparation, see p. 1000.

Preparation of Solutions

I. Glycine buffer (0.07 M; pH 9.3):

Dissolve 25 g. glycine in 200 ml. C02-free distilled water and add 110 ml. 1 N NaOH.

II. Uricase (200-300 units**)/ml.):

Dissolve the contents of a uricase ampoule (75 units) with 0.25 ml. buffer (solution I).

Or use the enzyme suspension undiluted.

Stability of the s o l u t i o n s

The enzyme solution is stable for at least 14 days in a refrigerator. The buffer keeps for several months providing bacterial contamination is avoided.

Procedure

Experimental material

Dilute plasma or serum (to contain 0.5—5.0 \ig. uric acid/ml.) 1:40 with buffer (solution I).

Dilute urine (to contain 2—4 \ig. uric acid/ml.) 1:400 with buffer (solution I). If the urine contains a large sediment and therefore a large amount of uric acid, dilute 1:10

3

. Dilute urine which is practically colourless 1:100. Further treatment is unnecessary.

Spectrophotometric m e a s u r e m e n t s

Wavelength: 293 mfx; silica or glass cuvettes, light path: 1 cm.; final volume: 3.01 ml.;

room temperature. Measure against a control cuvette.

The enzyme absorbs at 293 mu,. Although the optical density of the enzyme EE is usually negligible, it should be determined for each enzyme preparation.

*> Complete reagent kits are commercially available (see p. 1036).

**) A unit is the amount of enzyme which oxidizes 1 [ig. uric acid/min. at pH 9.3 (initial amount of uric acid = 5 [xg.). At 293 m[x a uricase unit causes an optical density change of 0.025 /min. in a 3 ml. assay mixture with a 1 cm. light path.

(2)

V . l . c Uric Acid 501

Pipette into the cuvette:

2.99 ml. buffer (solution I)

0.01 ml. uricase solution or suspension*) (II) (2—3 units).

Read the optical density EE against a blank cuvette containing 3 ml. buffer (solution I).

As the samples normally have a very high optical density at 293 mu (due to protein and other absorbing constituents) measurements are made against a control cuvette containing less sample than the experimental cuvette.

Pipette successively into the cuvettes:

Control cuvette: 2.40 ml. dilute serum or plasma 0.60 ml. buffer (solution I)

or 3.00 ml. distilled water for measurements of uric acid in urine Experimental cuvette: 3.00 ml. dilute sample.

Read the optical density Ei against the control cuvette **). Mix into the experimental cuvette 0.01 ml. uricase solution or suspension (II) (2—3 units).

On completion of the reaction (10—20 min.) read the optical density E2. Ej + EE— E2 = AE is used for the calculations.

If with large amounts of uric acid in the sample the value for E2 is negative, read the optical density of the control cuvette against the experimental cuvette. AE is then Ei + EE + E2. If the reading is off the scale, then measure the optical density E 3 of the experimental cuvette against a water blank and determine the optical density difference A EC of the control cuvette against the water blank. Then AE = Ei + EE— E 3 + AEC.

Calculations

With a 1 cm. light path the oxidation of 1 ug. uric acid/ml. corresponds to an optical density decrease of A E = 0.075 at 293 mu.

Therefore = ug. uric acid/mi. assay mixture. AE 0.075 ^

Owing to the preliminary dilution of the samples (plasma and serum 1:40, urine 1:400) it follows that:

AE

X 4 0 = ug. uric acid/ml. serum or plasma 0.075

•—— X 4 0 0 = ug. uric acid/ml. urine. AE 0.075

Multiplication o f these values by 0.1 gives the results in the usual clinical units o f mg. %.

Sources of Error

The determination is not interfered with by any substances present in the samples.

Specificity

Uricase is specific for uric acid.

*) The optical density of the amount of enzyme used for the assay must be small in relation to the measured optical density changes.

**) Usually values between 0.500 and 0.100 are obtained. If the optical densities are higher or lower vary the volume of sample in the control cuvette accordingly.

Hivatkozások

KAPCSOLÓDÓ DOKUMENTUMOK

b) On completion of the reaction in the assay system the optical density at 340mfji should remain constant for at least 10 minutes. If a glucose-6-phosphate dehydrogenase

Plot the optical densities (measured against the reagent blank) (ordinate) against the amounts of glucose (abscissa) and read off from this standard curve the amounts of

wait for the end of the reaction (increase in optical density caused by the G-6-P contained in the sample reacting according to equation (1)) and then read the optical density E

into the experimental cuvette and on completion of the reaction (3—5 min.) read the optical density E3 twice or more times at 3 min. To test if the assay is working correctly,

When the optical density no longer increases (5 —10 min. after the addition of the enzyme, depending on the 6-phosphogluconate concentration) read the optical density E 2 twice with

If the deproteinized sample contains TPN, then substitute distilled water for the enzyme solution in the control cuvette. On completion of the reaction read the optical density

The change in optical density due to the glycerokinase preparation can be obtained if on completion of the assay the same amount of enzyme is again pipetted into the cuvette.

follow the optical density until that of the experimental cuvette no longer decreases or the rate of decrease in optical density (AE/min.) is the same in the experimental and control